USE OF MAGNESIUM SULFATE IN HYPERTENSIVE DISORDERS OF PREGNANCY: A COMPARATIVE ANALYSIS OF NATIONAL AND INTERNATIONAL RECOMMENDATIONS FOR PRE-HOSPITAL CARE

Abstract

This article aimed to conduct a comparative analysis of key national and international recommendations regarding the use of magnesium sulfate in the pre-hospital care of pregnant and postpartum women with hypertensive disorders of pregnancy. This is an observational, descriptive narrative review involving a comparative analysis of national and international technical-scientific documents. The documents were purposively selected and subjected to systematic data extraction. The information was organized into matrices and comparative tables, followed by a critical analysis. Broad convergence was observed among the documents regarding the early administration of magnesium sulfate for the prevention and treatment of seizures in severe pre-eclampsia and eclampsia, as well as the need for clinical monitoring based on respiratory rate, deep tendon reflexes, and urine output. The main divergences centered on therapeutic regimens, routes of administration, and adaptations for different levels of care complexity. Brazilian protocols were found to be aligned with international recommendations, offering greater detail on specific procedures for pre-hospital care and the organization of care pathways. It is concluded that national and international recommendations show a high degree of agreement regarding the principles of magnesium sulfate therapy. Early administration of magnesium sulfate in pre-hospital care and the standardization of protocols are essential strategies for improving the quality of care and reducing complications.